Cargando…

Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease

Interstitial lung disease (ILD) is the leading cause of morbidity and mortality in systemic sclerosis (SSc). We performed a systematic review to characterise the use and validation of pulmonary function tests (PFTs) as surrogate markers for systemic sclerosis-associated interstitial lung disease (SS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caron, Melissa, Hoa, Sabrina, Hudson, Marie, Schwartzman, Kevin, Steele, Russell
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2018
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488607/ https://www.ncbi.nlm.nih.gov/pubmed/29769294 http://dx.doi.org/10.1183/16000617.0102-2017

Ejemplares similares

Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease
por: Le Gouellec, Noémie, et al.
Publicado: (2017)

Pulmonary function testing in children's interstitial lung disease
por: Ring, Astrid Madsen, et al.
Publicado: (2020)

Clinical characteristics and outcomes in pulmonary manifestations of systemic sclerosis: Contribution from pulmonary hypertension and interstitial lung disease severity
por: Sangani, Ruchika A., et al.
Publicado: (2022)

Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
por: Guillén-Del-Castillo, Alfredo, et al.
Publicado: (2022)

The Impact of Progressive Pulmonary Fibrosis in Systemic Sclerosis–Associated Interstitial Lung Disease
por: Martín-López, María, et al.
Publicado: (2023)

Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis
por: Zheng, Boyang, et al.
Publicado: (2023)

Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
por: Cottin, Vincent, et al.
Publicado: (2019)

Treatment and Systemic Sclerosis Interstitial Lung Disease Outcome: The Overweight Paradox
por: Nagy, Alexandra, et al.
Publicado: (2022)

The Challenge of Diagnosing and Managing Pulmonary Arterial Hypertension in Systemic Sclerosis with Interstitial Lung Disease
por: Zanatta, Elisabetta, et al.
Publicado: (2022)

Interstitial lung disease pathology in systemic sclerosis
por: Konopka, Kristine E., et al.
Publicado: (2021)

Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
por: Bergamasco, Aurore, et al.
Publicado: (2019)

Pulmonary Hemodynamics and Six-Minute Walk Test Outcomes in Patients with Interstitial Lung Disease
por: Nishiyama, Osamu, et al.
Publicado: (2016)

Improved pulmonary function following pirfenidone treatment in a patient with progressive interstitial lung disease associated with systemic sclerosis
por: Udwadia, Zarir F., et al.
Publicado: (2015)

Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
por: Guillén-Del-Castillo, Alfredo, et al.
Publicado: (2022)

Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis
por: Fairley, Jessica L., et al.
Publicado: (2023)

Circulating Biomarkers of Interstitial Lung Disease in Systemic Sclerosis
por: Lota, Harpreet K., et al.
Publicado: (2012)

Recent Treatments of Interstitial Lung Disease with Systemic Sclerosis
por: Yasuoka, Hidekata
Publicado: (2016)

Pathogenesis of systemic sclerosis associated interstitial lung disease
por: Nihtyanova, Svetlana I, et al.
Publicado: (2020)

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2021)

Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung disease
por: Kreuter, Michael, et al.
Publicado: (2022)

Pulmonary Ultrasonography in Systemic Sclerosis-Induced Interstitial Lung Disease—A Systematic Review and Meta-Analysis
por: Radić, Mislav, et al.
Publicado: (2023)

Incidence and prevalence of systemic sclerosis and systemic sclerosis with interstitial lung disease in the United States
por: Fan, Yanni, et al.
Publicado: (2020)

Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
por: Rahaghi, Franck F., et al.
Publicado: (2023)

Short-Term Lung Function Changes and Predictors of Progressive Systemic Sclerosis–Related Interstitial Lung Disease
por: Kaenmuang, Punchalee, et al.
Publicado: (2020)

Genetic Susceptibility to Interstitial Lung Disease Associated with Systemic Sclerosis
por: Tochimoto, Akiko, et al.
Publicado: (2016)

Difficulties in diagnosis of systemic sclerosis-related interstitial lung disease
por: Vrancken, Anniek, et al.
Publicado: (2015)

Rituximab treatment in patients with systemic sclerosis and interstitial lung disease
por: Mohammed, Abdel Gaffar A., et al.
Publicado: (2017)

Predictors of progression in systemic sclerosis patients with interstitial lung disease
por: Distler, Oliver, et al.
Publicado: (2020)

Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis
por: Khanna, Surabhi Agarwal, et al.
Publicado: (2022)

Ventilation distribution as a contributor to the functional exercise capacity in patients with systemic sclerosis-associated interstitial lung disease without pulmonary hypertension
por: Andrade, F.M., et al.
Publicado: (2019)

Ability of the COPD Assessment Test to evaluate the lung‐specific quality of life in systemic sclerosis‐associated interstitial lung disease
por: Mugii, Naoki, et al.
Publicado: (2020)

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis
por: Hudson, Marie, et al.
Publicado: (2012)

Reproducibility of pulmonary function tests in patients with systemic sclerosis
por: Jacquerie, P., et al.
Publicado: (2023)

Clinical Predictors of Lung-Function Decline in Systemic-Sclerosis-Associated Interstitial Lung Disease Patients with Normal Spirometry
por: Nagy, Tamas, et al.
Publicado: (2022)

The Effect of Anti‐Scl‐70 Antibody Determination Method on Its Predictive Significance for Interstitial Lung Disease Progression in Systemic Sclerosis
por: Jandali, Bochra, et al.
Publicado: (2022)

Computer-Aided Tomographic Analysis of Interstitial Lung Disease (ILD) in Patients with Systemic Sclerosis (SSc). Correlation with Pulmonary Physiologic Tests and Patient-Centred Measures of Perceived Dyspnea and Functional Disability
por: Salaffi, Fausto, et al.
Publicado: (2016)

Interstitial lung disease in systemic sclerosis: challenges in early diagnosis and management
por: Chowaniec, Małgorzata, et al.
Publicado: (2018)

Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature
por: Bonhomme, Olivier, et al.
Publicado: (2019)

Patient and Physician Perspectives on Systemic Sclerosis–Associated Interstitial Lung Disease
por: Cheema, Tariq J, et al.
Publicado: (2020)

Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
por: Khanna, Dinesh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8082nd0u9ahi2koimd83c1tda2